The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Cannabinoids are found in the cannabis plant, they can be produced in biosynthesis way. While biosynthesis has not yet proven itself as a scalable technology, it has the potential to radically alter the way cannabinoids are manufactured in the near future.These compounds are the exact same as what cannabis expresses.
The global Biosynthesis of Cannabinoids market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Biosynthesis of Cannabinoids is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Biosynthesis of Cannabinoids is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Biosynthesis of Cannabinoids in Food Industry is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Biosynthesis of Cannabinoids include Anandia Laboratories, Gingko Bioworks, Hyasynth Bio, InMed Pharmaceuticals, Librede, Renew Biopharma, Cronos Group, Organigram and Teewinot Life Sciences, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Biosynthesis of Cannabinoids, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biosynthesis of Cannabinoids.
Report Scope
The Biosynthesis of Cannabinoids market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biosynthesis of Cannabinoids market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biosynthesis of Cannabinoids companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- Anandia Laboratories
- Gingko Bioworks
- Hyasynth Bio
- InMed Pharmaceuticals
- Librede
- Renew Biopharma
- Cronos Group
- Organigram
- Teewinot Life Sciences
- ICC International Cannabis Corp.
- Biotii Technologies Corp.
- Bristol-Myers Squibb
- Biogen Inc.
- GW Pharmaceuticals
Segment by Type
- THC
- CBD
- Others
Segment by Application
- Food Industry
- Medical Industry
- Others
By Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Netherlands)
- Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
- Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biosynthesis of Cannabinoids companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biosynthesis of Cannabinoids Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 THC
1.2.3 CBD
1.2.4 Others
1.3 Market by Application
1.3.1 Global Biosynthesis of Cannabinoids Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Food Industry
1.3.3 Medical Industry
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biosynthesis of Cannabinoids Market Perspective (2019-2030)
2.2 Biosynthesis of Cannabinoids Growth Trends by Region
2.2.1 Global Biosynthesis of Cannabinoids Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Biosynthesis of Cannabinoids Historic Market Size by Region (2019-2024)
2.2.3 Biosynthesis of Cannabinoids Forecasted Market Size by Region (2025-2030)
2.3 Biosynthesis of Cannabinoids Market Dynamics
2.3.1 Biosynthesis of Cannabinoids Industry Trends
2.3.2 Biosynthesis of Cannabinoids Market Drivers
2.3.3 Biosynthesis of Cannabinoids Market Challenges
2.3.4 Biosynthesis of Cannabinoids Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biosynthesis of Cannabinoids Players by Revenue
3.1.1 Global Top Biosynthesis of Cannabinoids Players by Revenue (2019-2024)
3.1.2 Global Biosynthesis of Cannabinoids Revenue Market Share by Players (2019-2024)
3.2 Global Biosynthesis of Cannabinoids Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biosynthesis of Cannabinoids Revenue
3.4 Global Biosynthesis of Cannabinoids Market Concentration Ratio
3.4.1 Global Biosynthesis of Cannabinoids Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biosynthesis of Cannabinoids Revenue in 2023
3.5 Biosynthesis of Cannabinoids Key Players Head office and Area Served
3.6 Key Players Biosynthesis of Cannabinoids Product Solution and Service
3.7 Date of Enter into Biosynthesis of Cannabinoids Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biosynthesis of Cannabinoids Breakdown Data by Type
4.1 Global Biosynthesis of Cannabinoids Historic Market Size by Type (2019-2024)
4.2 Global Biosynthesis of Cannabinoids Forecasted Market Size by Type (2025-2030)
5 Biosynthesis of Cannabinoids Breakdown Data by Application
5.1 Global Biosynthesis of Cannabinoids Historic Market Size by Application (2019-2024)
5.2 Global Biosynthesis of Cannabinoids Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Biosynthesis of Cannabinoids Market Size (2019-2030)
6.2 North America Biosynthesis of Cannabinoids Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Biosynthesis of Cannabinoids Market Size by Country (2019-2024)
6.4 North America Biosynthesis of Cannabinoids Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biosynthesis of Cannabinoids Market Size (2019-2030)
7.2 Europe Biosynthesis of Cannabinoids Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Biosynthesis of Cannabinoids Market Size by Country (2019-2024)
7.4 Europe Biosynthesis of Cannabinoids Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biosynthesis of Cannabinoids Market Size (2019-2030)
8.2 Asia-Pacific Biosynthesis of Cannabinoids Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Biosynthesis of Cannabinoids Market Size by Region (2019-2024)
8.4 Asia-Pacific Biosynthesis of Cannabinoids Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biosynthesis of Cannabinoids Market Size (2019-2030)
9.2 Latin America Biosynthesis of Cannabinoids Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Biosynthesis of Cannabinoids Market Size by Country (2019-2024)
9.4 Latin America Biosynthesis of Cannabinoids Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biosynthesis of Cannabinoids Market Size (2019-2030)
10.2 Middle East & Africa Biosynthesis of Cannabinoids Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Biosynthesis of Cannabinoids Market Size by Country (2019-2024)
10.4 Middle East & Africa Biosynthesis of Cannabinoids Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Anandia Laboratories
11.1.1 Anandia Laboratories Company Detail
11.1.2 Anandia Laboratories Business Overview
11.1.3 Anandia Laboratories Biosynthesis of Cannabinoids Introduction
11.1.4 Anandia Laboratories Revenue in Biosynthesis of Cannabinoids Business (2019-2024)
11.1.5 Anandia Laboratories Recent Development
11.2 Gingko Bioworks
11.2.1 Gingko Bioworks Company Detail
11.2.2 Gingko Bioworks Business Overview
11.2.3 Gingko Bioworks Biosynthesis of Cannabinoids Introduction
11.2.4 Gingko Bioworks Revenue in Biosynthesis of Cannabinoids Business (2019-2024)
11.2.5 Gingko Bioworks Recent Development
11.3 Hyasynth Bio
11.3.1 Hyasynth Bio Company Detail
11.3.2 Hyasynth Bio Business Overview
11.3.3 Hyasynth Bio Biosynthesis of Cannabinoids Introduction
11.3.4 Hyasynth Bio Revenue in Biosynthesis of Cannabinoids Business (2019-2024)
11.3.5 Hyasynth Bio Recent Development
11.4 InMed Pharmaceuticals
11.4.1 InMed Pharmaceuticals Company Detail
11.4.2 InMed Pharmaceuticals Business Overview
11.4.3 InMed Pharmaceuticals Biosynthesis of Cannabinoids Introduction
11.4.4 InMed Pharmaceuticals Revenue in Biosynthesis of Cannabinoids Business (2019-2024)
11.4.5 InMed Pharmaceuticals Recent Development
11.5 Librede
11.5.1 Librede Company Detail
11.5.2 Librede Business Overview
11.5.3 Librede Biosynthesis of Cannabinoids Introduction
11.5.4 Librede Revenue in Biosynthesis of Cannabinoids Business (2019-2024)
11.5.5 Librede Recent Development
11.6 Renew Biopharma
11.6.1 Renew Biopharma Company Detail
11.6.2 Renew Biopharma Business Overview
11.6.3 Renew Biopharma Biosynthesis of Cannabinoids Introduction
11.6.4 Renew Biopharma Revenue in Biosynthesis of Cannabinoids Business (2019-2024)
11.6.5 Renew Biopharma Recent Development
11.7 Cronos Group
11.7.1 Cronos Group Company Detail
11.7.2 Cronos Group Business Overview
11.7.3 Cronos Group Biosynthesis of Cannabinoids Introduction
11.7.4 Cronos Group Revenue in Biosynthesis of Cannabinoids Business (2019-2024)
11.7.5 Cronos Group Recent Development
11.8 Organigram
11.8.1 Organigram Company Detail
11.8.2 Organigram Business Overview
11.8.3 Organigram Biosynthesis of Cannabinoids Introduction
11.8.4 Organigram Revenue in Biosynthesis of Cannabinoids Business (2019-2024)
11.8.5 Organigram Recent Development
11.9 Teewinot Life Sciences
11.9.1 Teewinot Life Sciences Company Detail
11.9.2 Teewinot Life Sciences Business Overview
11.9.3 Teewinot Life Sciences Biosynthesis of Cannabinoids Introduction
11.9.4 Teewinot Life Sciences Revenue in Biosynthesis of Cannabinoids Business (2019-2024)
11.9.5 Teewinot Life Sciences Recent Development
11.10 ICC International Cannabis Corp.
11.10.1 ICC International Cannabis Corp. Company Detail
11.10.2 ICC International Cannabis Corp. Business Overview
11.10.3 ICC International Cannabis Corp. Biosynthesis of Cannabinoids Introduction
11.10.4 ICC International Cannabis Corp. Revenue in Biosynthesis of Cannabinoids Business (2019-2024)
11.10.5 ICC International Cannabis Corp. Recent Development
11.11 Biotii Technologies Corp.
11.11.1 Biotii Technologies Corp. Company Detail
11.11.2 Biotii Technologies Corp. Business Overview
11.11.3 Biotii Technologies Corp. Biosynthesis of Cannabinoids Introduction
11.11.4 Biotii Technologies Corp. Revenue in Biosynthesis of Cannabinoids Business (2019-2024)
11.11.5 Biotii Technologies Corp. Recent Development
11.12 Bristol-Myers Squibb
11.12.1 Bristol-Myers Squibb Company Detail
11.12.2 Bristol-Myers Squibb Business Overview
11.12.3 Bristol-Myers Squibb Biosynthesis of Cannabinoids Introduction
11.12.4 Bristol-Myers Squibb Revenue in Biosynthesis of Cannabinoids Business (2019-2024)
11.12.5 Bristol-Myers Squibb Recent Development
11.13 Biogen Inc.
11.13.1 Biogen Inc. Company Detail
11.13.2 Biogen Inc. Business Overview
11.13.3 Biogen Inc. Biosynthesis of Cannabinoids Introduction
11.13.4 Biogen Inc. Revenue in Biosynthesis of Cannabinoids Business (2019-2024)
11.13.5 Biogen Inc. Recent Development
11.14 GW Pharmaceuticals
11.14.1 GW Pharmaceuticals Company Detail
11.14.2 GW Pharmaceuticals Business Overview
11.14.3 GW Pharmaceuticals Biosynthesis of Cannabinoids Introduction
11.14.4 GW Pharmaceuticals Revenue in Biosynthesis of Cannabinoids Business (2019-2024)
11.14.5 GW Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
